Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution-Letter

被引:1
|
作者
Claeys, Arne [1 ,2 ]
Eynden, Jimmy Van den [1 ,2 ]
机构
[1] Univ Ghent, Dept Human Struct & Repair, Anat & Embryol Unit, Ghent, Belgium
[2] Canc Res Inst Ghent, Ghent, Belgium
关键词
D O I
10.1158/0008-5472.CAN-22-2497
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:971 / 972
页数:2
相关论文
共 50 条
  • [1] Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution
    Wu, Tao
    Wang, Guangshuai
    Wang, Xuan
    Wang, Shixiang
    Zhao, Xiangyu
    Wu, Chenxu
    Ning, Wei
    Tao, Ziyu
    Chen, Fuxiang
    Liu, Xue-Song
    CANCER RESEARCH, 2022, 82 (12) : 2226 - 2238
  • [2] Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution-Reply
    Wu, Tao
    Diao, Kaixuan
    Liu, Xue-Song
    CANCER RESEARCH, 2023, 83 (06) : 973 - 973
  • [3] Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
    Marta Łuksza
    Zachary M. Sethna
    Luis A. Rojas
    Jayon Lihm
    Barbara Bravi
    Yuval Elhanati
    Kevin Soares
    Masataka Amisaki
    Anton Dobrin
    David Hoyos
    Pablo Guasp
    Abderezak Zebboudj
    Rebecca Yu
    Adrienne Kaya Chandra
    Theresa Waters
    Zagaa Odgerel
    Joanne Leung
    Rajya Kappagantula
    Alvin Makohon-Moore
    Amber Johns
    Anthony Gill
    Mathieu Gigoux
    Jedd Wolchok
    Taha Merghoub
    Michel Sadelain
    Erin Patterson
    Remi Monasson
    Thierry Mora
    Aleksandra M. Walczak
    Simona Cocco
    Christine Iacobuzio-Donahue
    Benjamin D. Greenbaum
    Vinod P. Balachandran
    Nature, 2022, 606 : 389 - 395
  • [4] Lack of immunoediting in murine pancreatic cancer reversed with neoantigen
    Evans, Rebecca A.
    Diamond, Mark S.
    Rech, Andrew J.
    Chao, Timothy
    Richardson, Max W.
    Lin, Jeffrey H.
    Bajor, David L.
    Byrne, Katelyn T.
    Stanger, Ben Z.
    Riley, James L.
    Markosyan, Nune
    Winograd, Rafael
    Vonderheide, Robert H.
    JCI INSIGHT, 2016, 1 (14):
  • [5] Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
    Luksza, Marta
    Sethna, Zachary M.
    Rojas, Luis A.
    Lihm, Jayon
    Bravi, Barbara
    Elhanati, Yuval
    Soares, Kevin
    Amisaki, Masataka
    Dobrin, Anton
    Hoyos, David
    Guasp, Pablo
    Zebboudj, Abderezak
    Yu, Rebecca
    Chandra, Adrienne Kaya
    Waters, Theresa
    Odgerel, Zagaa
    Leung, Joanne
    Kappagantula, Rajya
    Makohon-Moore, Alvin
    Johns, Amber
    Gill, Anthony
    Gigoux, Mathieu
    Wolchok, Jedd
    Merghoub, Taha
    Sadelain, Michel
    Patterson, Erin
    Monasson, Remi
    Mora, Thierry
    Walczak, Aleksandra M.
    Cocco, Simona
    Iacobuzio-Donahue, Christine
    Greenbaum, Benjamin D.
    Balachandran, Vinod P.
    NATURE, 2022, 606 (7913) : 389 - +
  • [6] Computational Quantification of Cancer Immunoediting
    Liu, Kun
    He, Shengyuan
    Sun, Shangqin
    Zhang, Xinxin
    He, Yanzhen
    Quan, Fei
    Pang, Bo
    Xiao, Yun
    CANCER IMMUNOLOGY RESEARCH, 2023, 11 (09) : 1159 - 1167
  • [7] The shared mutation and neoantigen landscape of MMR-deficient colorectal cancers suggests immunoediting during tumor evolution
    Kloor, Matthias
    Ballhausen, Alexej
    Przybilla, Moritz
    Jendrusch, Michael
    Pfaffendorf, Elisabeth
    Draxlbauer, Markus
    Seidler, Florian
    Krausert, Sonja
    Ahadova, Aysel
    Kalteis, Simon
    Heid, Daniel
    Gebert, Johannes
    Bonsack, Maria
    Schott, Sarah
    Blaeker, Hendrik
    Seppala, Toni
    Mecklin, Jukka-Pekka
    Ten Broeke, Sanne
    Nielsen, Maartje
    Krzykalla, Julia
    Benner, Axel
    Riemer, Angelika
    Doeberitz, Magnus von Knebel
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Modeling tumor immunoediting under immune selective pressure to inform neoantigen landscape dynamics for effective cancer vaccines
    George, Mariam Mathew
    Lihm, Jayon
    Choi, Hyejin
    Elhanati, Yuval
    Martis, Stephen
    Luksza, Marta
    Greenbaum, Benjamin
    Wolchok, Jedd D.
    Merghoub, Taha
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Evidence of Tumor Immunoediting in Pediatric Cancer Subtypes Through In-Silico Prediction of MHC-I Neoantigen Presentation
    Ozog, S.
    Castro, A.
    Murshed, F.
    Montesion, M.
    Carter, H.
    Kuo, D.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S372 - S373
  • [10] Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
    Houlahan, Kathleen
    Khan, Aziz
    Greenwald, Noah
    Vivas, Cristina Sotomayor
    West, Robert B.
    Angelo, Michael
    Curtis, Christina
    CANCER RESEARCH, 2024, 84 (07)